您的位置: 首页 > 农业专利 > 详情页

INHIBITION DE LA CHIMIOKINE CCL7 OU DE SON RECEPTEUR CCR3 POUR LE TRAITEMENT ET LE DIAGNOSTIC DU CANCER DE LA PROSTATE
专利权人:
Université Paul Sabatier (Toulouse III)
发明人:
MULLER, Catherine,LAURENT, Victor,GUERARD, Adrien,VALET, Philippe,MALAVAUD, Bernard
申请号:
EP15738477.7
公开号:
EP3155010A1
申请日:
2015.06.16
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The invention concerns an inhibitor of the expression of chemokine CCL7 or an inhibitor of the expression of the receptor CCR3 or an inhibitor of CCL7/CCR3 interaction for the use of same to prevent or treat the extension of prostate cancer outside the prostatic capsule in a subject. The invention also concerns a method for determining the degree of aggressiveness of a prostate cancer tumour in a subject suffering from prostate cancer, comprising a step of determining the concentration or level of expression of the receptor CCR3 in a sample of prostate tumour cells obtained from said subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充